Sarthak Metals Ltd
NSE:SMLT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sarthak Metals Ltd
NSE:SMLT
|
IN |
|
Accenture PLC
NYSE:ACN
|
IE |
|
Shanghai Film Co Ltd
SSE:601595
|
CN |
|
Arcelik AS
IST:ARCLK.E
|
TR |
|
Y
|
Yantai North Andre Juice Co Ltd
SSE:605198
|
CN |
|
Amazia Inc
TSE:4424
|
JP |
|
Yamazaki Baking Co Ltd
TSE:2212
|
JP |
|
I
|
Integrated Design & Engineering Holdings Co Ltd
TSE:9161
|
JP |
|
Willow Biosciences Inc
TSX:WLLW
|
CA |
|
C
|
Ching Feng Home Fashions Co Ltd
TWSE:9935
|
TW |
|
Shoulder Innovations Inc
NYSE:SI
|
US |
|
Qingdao Haier Biomedical Co Ltd
SSE:688139
|
CN |
|
A
|
Arctic Blue Beverages AB
STO:ARCTIC
|
SE |
Balance Sheet
Balance Sheet Decomposition
Sarthak Metals Ltd
Sarthak Metals Ltd
Balance Sheet
Sarthak Metals Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
23
|
10
|
15
|
14
|
15
|
89
|
16
|
35
|
13
|
35
|
78
|
144
|
354
|
24
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
13
|
144
|
191
|
24
|
|
| Cash Equivalents |
23
|
10
|
15
|
14
|
15
|
89
|
16
|
35
|
13
|
18
|
65
|
0
|
164
|
0
|
|
| Total Receivables |
149
|
222
|
205
|
261
|
279
|
330
|
320
|
295
|
330
|
382
|
568
|
590
|
427
|
457
|
|
| Accounts Receivables |
142
|
214
|
201
|
247
|
250
|
298
|
291
|
232
|
282
|
382
|
568
|
531
|
397
|
425
|
|
| Other Receivables |
8
|
8
|
4
|
14
|
29
|
32
|
29
|
63
|
48
|
0
|
0
|
60
|
30
|
32
|
|
| Inventory |
50
|
67
|
105
|
108
|
107
|
102
|
156
|
261
|
219
|
298
|
281
|
215
|
259
|
290
|
|
| Other Current Assets |
0
|
0
|
1
|
0
|
0
|
0
|
52
|
92
|
20
|
42
|
96
|
8
|
2
|
9
|
|
| Total Current Assets |
222
|
299
|
325
|
383
|
401
|
521
|
544
|
683
|
582
|
756
|
1 023
|
957
|
1 042
|
1 042
|
|
| PP&E Net |
58
|
52
|
58
|
77
|
66
|
90
|
93
|
140
|
145
|
137
|
113
|
128
|
153
|
197
|
|
| PP&E Gross |
58
|
52
|
58
|
77
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
128
|
153
|
197
|
|
| Accumulated Depreciation |
38
|
50
|
60
|
70
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
118
|
132
|
158
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
27
|
16
|
15
|
5
|
0
|
5
|
4
|
7
|
28
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
5
|
8
|
8
|
8
|
8
|
8
|
8
|
19
|
25
|
15
|
4
|
5
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
15
|
2
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
306
N/A
|
367
+20%
|
402
+10%
|
472
+17%
|
489
+4%
|
627
+28%
|
651
+4%
|
838
+29%
|
763
-9%
|
913
+20%
|
1 161
+27%
|
1 100
-5%
|
1 199
+9%
|
1 244
+4%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
4
|
5
|
16
|
16
|
2
|
4
|
9
|
35
|
39
|
7
|
103
|
5
|
1
|
10
|
|
| Short-Term Debt |
144
|
189
|
184
|
229
|
228
|
262
|
236
|
334
|
218
|
246
|
181
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
3
|
0
|
0
|
0
|
0
|
22
|
17
|
0
|
0
|
0
|
|
| Other Current Liabilities |
15
|
8
|
10
|
10
|
11
|
22
|
15
|
14
|
20
|
54
|
47
|
35
|
25
|
17
|
|
| Total Current Liabilities |
163
|
201
|
209
|
255
|
243
|
288
|
260
|
382
|
277
|
328
|
347
|
40
|
26
|
27
|
|
| Long-Term Debt |
15
|
11
|
12
|
7
|
4
|
10
|
23
|
28
|
16
|
44
|
26
|
0
|
0
|
0
|
|
| Deferred Income Tax |
1
|
1
|
1
|
1
|
1
|
2
|
0
|
1
|
2
|
3
|
1
|
1
|
2
|
3
|
|
| Other Liabilities |
2
|
3
|
3
|
4
|
1
|
1
|
2
|
4
|
6
|
7
|
7
|
8
|
10
|
13
|
|
| Total Liabilities |
181
N/A
|
216
+19%
|
225
+4%
|
266
+18%
|
250
-6%
|
301
+20%
|
285
-5%
|
415
+45%
|
301
-27%
|
382
+27%
|
381
0%
|
50
-87%
|
38
-23%
|
42
+10%
|
|
| Equity | |||||||||||||||
| Common Stock |
40
|
81
|
121
|
121
|
121
|
137
|
137
|
137
|
137
|
137
|
137
|
137
|
137
|
137
|
|
| Retained Earnings |
85
|
70
|
57
|
85
|
118
|
190
|
229
|
287
|
325
|
394
|
643
|
870
|
981
|
1 022
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
43
|
43
|
43
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
126
N/A
|
151
+20%
|
177
+18%
|
206
+16%
|
239
+16%
|
327
+37%
|
366
+12%
|
424
+16%
|
462
+9%
|
531
+15%
|
779
+47%
|
1 050
+35%
|
1 161
+11%
|
1 202
+4%
|
|
| Total Liabilities & Equity |
306
N/A
|
367
+20%
|
402
+10%
|
472
+17%
|
489
+4%
|
627
+28%
|
651
+4%
|
838
+29%
|
763
-9%
|
913
+20%
|
1 161
+27%
|
1 100
-5%
|
1 199
+9%
|
1 244
+4%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
14
|
|